eShowcase: Oracle Initiatives Focus on Drug Safety

January 1, 2008

Applied Clinical Trials

Applied Clinical Trials, Applied Clinical Trials-01-01-2008, Volume 0, Issue 0

Recent announcements streamline adverse event reporting

Recent announcements streamline adverse event reporting

Oracle (Redwood Shores, CA) announced Safety in a Capsule, an IT and service collaboration between Oracle, Tata Consultancy Services (TCS), and DrugLogic. The offering combines Oracle's Siebel Contact Center Integration Pack for Oracle's Adverse Event Reporting (AER) System, DrugLogic's signal detection solution QScan, and TCS' Knowledge Process Outsourcing services to monitor and analyze pre- and postmarketing AER data for increased drug safety.

The Siebel Contact Center Integration Pack for the Oracle AER passes customer, product complaint, and potential AER information from the contact center to automatically load event-related information into the Oracle AER system. This solution works to reduce duplicate data entry, conflict resolution, and reconciliation. It is part of the Oracle Application Integration Architecture.

Oracle, (800) 672-2531, www.oracle.com

Related Content:

News